COVID-19 vaccine trial at UW Health still on hold as Trump, FDA clash on approval rules

FluGen, based on research by UW-Madison scientists Yoshihiro Kawaoka and Gabriele Neumann, is adapting its experimental flu vaccine to target COVID-19 and flu. The candidate, CoroFlu, is being developed with Bharat Biotech, in Hyderabad, India, and could enter a human trial in India by late this year, FluGen CEO Paul Radspinner said in August.